Gene delivery from the E3 region of replicating human adenovirus: evaluation of the E3B region (Q40785394)

23 September 2017

title

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the E3B region (English)

1 reference

23 September 2017

1 reference

Hawkins LK

1

1 reference

23 September 2017

Hermiston T

series ordinal

2

1 reference

23 September 2017

publication date

1 August 2001

1 reference

23 September 2017

1 reference

23 September 2017

volume

8

1 reference

23 September 2017

issue

15

1 reference

23 September 2017

page(s)

1142-1148

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301509

23 September 2017

exact match

0 references

cites work

Replication-selective adenoviruses as oncolytic agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the 6.7 K/gp19 K region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the ADP region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

Epidermal growth factor receptor is down-regulated by a 10,400 MW protein encoded by the E3 region of adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

An endotoxin-induced serum factor that causes necrosis of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

Tumor necrosis factor (TNF) alpha: control of TNF-sensitivity and molecular mechanisms of TNF-mediated growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

Tumor necrosis factor-alpha and Fas activate complementary Fas-associated death domain-dependent pathways that enhance apoptosis induced by gamma-irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

Rationale for using TNF alpha and chemotherapy in regional therapy of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

Isolated limb perfusion with TNF alpha and melphalan in a rat osteosarcoma model: a new anti-tumour approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

DNA sequence of the deletion/insertion in early region 3 of Ad5 dl309.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

Down-regulation of human adenovirus E1a by E3 gene products: evidence for translational control of E1a by E3 14.5K and/or E3 10.4K products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

The E3-11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: characterization of cells infected with adp mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

Processing of tumour necrosis factor-α precursor by metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

ONYX-015: clinical data are encouraging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

7 January 2021

Interaction of the adenovirus 14.7-kDa protein with FLICE inhibits Fas ligand-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

7 January 2021

Effect of tumour necrosis factor on cultured human melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

7 January 2021

Limb desmoid tumors: a possible role for isolated limb perfusion with tumor necrosis factor-alpha and melphalan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

7 January 2021

Recombinant human tumor necrosis factor-alpha: thrombus formation is a cause of anti-tumor activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

7 January 2021

In vitro remodeling of tumor vascular endothelial cells using conditioned medium from various tumor cells and their sensitivity to TNF-alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

7 January 2021

High dose recombinant tumour necrosis factor (rTNF alpha) administered by isolation perfusion for advanced tumours of the limbs: a model for biochemotherapy of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

7 January 2021

Synergistic antitumour effect of recombinant human tumour necrosis factor alpha with melphalan in isolated limb perfusion in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301509

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301509

1 reference

Dimensions Publication ID

23 September 2017

1010537663

0 references

1 reference